medical-communications
(37)
eNOVA and the art of getting everyone in the room
A medical communications team and a software company joined forces to connect the moving parts of life sciences engagement. The revealing details are in the invitations, the content and the connection check.
Prezent wants your evenings back.
The presentation company is making a bigger bet: pair AI with medical communications experts, and sell life sciences teams a finished job instead of another blank slide.
The Health Agency That Learned to Say No
M Booth Health spent years proving that specialist knowledge and consumer creativity could share an office. Then 2025 took away two large pieces of revenue - and the agency discovered that its sharpest growth tool was refusing most of the work offered to it.
The Agency That Bought the Missing Pieces
Spectrum Science began with a narrow conviction: complicated medicine deserves clear storytelling. Three decades and a run of acquisitions later, the more interesting product is the machinery behind the message.
The Hardest Part of a Breakthrough Is Explaining It
SIMPSON Healthcare built a business in the narrow gap between discovering a therapy and making its science understood. Inside IQVIA, that small Connecticut agency now has a much larger map.
The Company That Turned the Dinner Lecture Into a Compliance Machine
L&M built a business around the least glamorous parts of pharmaceutical education - contracts, dinner limits, speaker training, audit trails - then made the machinery valuable enough for Fingerpaint Group to buy it.
The Agency That Turned One Nutrient Into a Whole Medicine Cabinet
Calcium+Company built a health-marketing group around a surprisingly sticky idea: brands, like bodies, need more than one nutrient. The interesting part is not the pun. It is the operating model hiding underneath it.
The Company Selling Confidence Before a Medicine Can Be Sold
A drug can work perfectly and still fail to reach patients. OPEN Health built a global consultancy around the awkward middle - the evidence, access, education, and human judgment that turn a scientific result into a confident decision.
The Healthcare Agency That Put Fear in a Fuzzy Pink Suit
SFC Group built a virtual healthcare agency around a small bet: regulated work does not have to sound institutional. A one-eyed mammogram mascot shows what happens when strategy, wit, and medical guardrails share the same room.
The Health Agency That Bought the Missing Pieces
JPA Health began with an unfashionable idea: healthcare messages work better when the people who understand policy, patients, science and data sit at the same table. Then it spent two years buying the chairs it was missing.
The Agency That Learned to Buy Its Way Out of a Bad Year
Real Chemistry began as one consultant with a healthcare Rolodex. A bruising 2008 taught it a stranger lesson: when clients need several kinds of expertise at once, the agency itself has to become a portfolio.
The Deck That Went Nowhere
A year of careful medical-communications work once died unused in the field. Kinetix Health Group is betting that pharma does not need another deck - it needs a system that keeps evidence moving.
The $245 Million Bet on the Middle of the Patient Journey
ConcentricLife discovered that the weak point in pharmaceutical advertising was not the advertisement. It was everything around it - the patient, the prescriber, the data, the access and the organization expected to make them agree.
Decera Clinical Is Building the Missing Mile Between a Breakthrough and a Bedside
The science was never the whole problem. Decera Clinical has assembled education, clinician insight, and medical communications into one machine for the awkward last mile - getting new evidence understood, trusted, and used.
Premier Healthcare Runs the Part of Pharma Nobody Applauds
The slide deck gets the attention. Premier Healthcare makes the science, training, payments and compliance behind it behave like one system.
Ogilvy Health’s Real Product Is Translation
A health campaign has to satisfy the scientist, the regulator, the payer, the physician, the patient, and the person scrolling at lunch. Ogilvy Health built one company to keep all six in the room.
The Medical Meeting That Refuses to End
Impact Communication Partners has spent more than four decades translating complicated science for healthcare professionals. Its sharpest idea is also its simplest: the best answer may arrive after the meeting is over.
The Drug Launch Has Too Many Translators
Citrus Health Group bought its way across the pharmaceutical launch journey. The clever part is not owning every specialty - it is deciding when each one enters the room.
RevHealth Put the Boring Parts on Fast-Forward
A private-equity transition dented revenue. RevHealth's answer was not a louder campaign, but a quieter reinvention of the agency workflow - putting medical, access, creative and AI in the same room before the brief hardens.
Synchrony Group and the Art of Making Medicine Make Sense
The West Chester agency built two businesses around one stubborn problem: good science is useless if nobody can understand, approve, or act on it.
The Agency That Learned Persuasion Has Side Effects
Publicis Health built a global machine for making medicine understandable. Then a $350 million settlement made the industry confront a harder question: what happens when the machine works too well?
The Agency Behind the Medicine Behind the Message
HCG built a business around an awkward truth: a medicine can work perfectly in a trial and still fail in the world if nobody understands it. Its answer was to put scientists, storytellers, designers, and regulatory specialists at the same table.
Assembled Intelligence and the Art of Making One Brief Do Nine Jobs
Four specialist agencies, nine capabilities and one expensive promise: that a drug launch gets smarter when the scientists, creatives, data analysts and access strategists stop passing the brief around.
M Health Makes Healthcare Marketing by Hand
In an industry built for scale, this Philadelphia consultancy has made a business of resisting the assembly line - turning medical evidence, human behavior and stubborn constraints into communications people can actually use.
When Public Relations Became Too Small for LifeSci
The agency began with a narrow label and kept adding jobs until the label broke. Its answer is a useful lesson in how to sell difficult science: put the people who understand it beside the people who know how to make others care.
The Tiny Agency Behind the Footnotes
Kay Square Scientific turns clinical data into the papers, posters and expert conversations that medicine runs on. Its advantage is not size, but a small remote team with long memories, advanced degrees and an almost fussy respect for the footnote.
The Medical Meeting That Wouldn’t Stay Small
One advisory board, a folding table and 3,000 envelopes became a 25-year medical communications company. JB Ashtin’s real product is the thing agencies rarely put on an invoice: trust under pressure.
The Scientists Had the Breakthrough. TellMed Had to Make Anyone Care.
A New Jersey agency found a business in the awkward distance between a scientific result and a human reaction. Its product is not publicity so much as translation - with enough regulatory discipline to survive the trip.
The Best Therapy in the World Still Needs Someone to Say Yes
MEYA Health works in the awkward distance between scientific approval and real-world access - where evidence must become a story that payers, health systems and field teams can actually use.
McCann Health Put the Medical Record on a Child’s Wrist
The agency’s sharpest ideas did not ask people to learn a new behavior. They hid better health inside habits people already trusted - a bracelet, a loaf of bread, a breath into a phone.